clinical trial

NOLA to offer Gallium 68 Scan Study
news

NEW ORLEANS – Ochsner Medical Center – Kenner and the New Orleans Neuroendocrine Tumor Specialists (NOLANETS) have launched the Gallium 68 Scan Study to test the effectiveness of this diagnostic tool to detect neuroendocrine tumors. Ochsner – Kenner is the only site from Louisiana through the Florida Panhandle to offer this groundbreaking diagnostic tool in a clinical trial. While most people may not be familiar with rare neuroendocrine tumors, they

As patients living with neuroendocrine tumors and carcinoid cancers, we have different options to choose from. The pages below explore some of the options we have, living with a rare cancer. Monitoring Disease There are a number of ways that neuroendocrine tumors are monitored through imaging and bloodwork. Standard Treatment Options First line treatment options or standard treatment options for all neuroendocrine cancers including Carcinoid. Complementary Treatment Options These are